Literature DB >> 1618203

Amyloid cardiomyopathy in systemic non-hereditary amyloidosis. Clinical, echocardiographic and electrocardiographic findings in 30 patients with AA and 24 patients with AL amyloidosis.

J P Hamer1, S Janssen, M H van Rijswijk, K I Lie.   

Abstract

To underline the role of echocardiography in the detection of cardiac involvement in patients with amyloidosis, physical examination, echocardiography and electrocardiography were performed in 30 patients with AA amyloidosis (amyloid protein A, associated with chronic inflammatory disease, usually without cardiomyopathy) and 24 patients with AL amyloidosis (the immunoglobulin light chain derived type, often associated with cardiomyopathy). All patients had histological confirmation of amyloidosis by rectal or subcutaneous abdominal fat biopsy. The combination of increased thickness of the left ventricular posterior wall and interventricular septum with a low voltage electrocardiographic pattern is highly specific for cardiac amyloidosis and was found in 3/30 (10%) of the AA patients and in 13/24 (54%) of the AL patients. The echocardiographic abnormalities were strongly related to the degree of clinical heart disease, showing mildly or moderately increased wall thickness in the early asymptomatic phase or severe thickening and hypokinesia of the left ventricular posterior wall and interventricular septum in clinically apparent cardiac dysfunction. Echocardiography appears to be a sensitive test for the detection of cardiac involvement in amyloidosis, in symptomatic as well as asymptomatic patients.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1618203     DOI: 10.1093/oxfordjournals.eurheartj.a060225

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  17 in total

1.  Hereditary cardiac amyloidosis associated with the transthyretin Ile122 mutation in a white man.

Authors:  J D Gillmore; D R Booth; M B Pepys; P N Hawkins
Journal:  Heart       Date:  1999-09       Impact factor: 5.994

2.  Role of echocardiography in assessing cardiac amyloidoses: a systematic review.

Authors:  Jun Koyama; Masatoshi Minamisawa; Yoshiki Sekijima; Koichiro Kuwahara; Tsutomu Katsuyama; Kazutoshi Maruyama
Journal:  J Echocardiogr       Date:  2019-02-11

3.  Familial and primary (AL) cardiac amyloidosis: echocardiographically similar diseases with distinctly different clinical outcomes.

Authors:  S W Dubrey; K Cha; M Skinner; M LaValley; R H Falk
Journal:  Heart       Date:  1997-07       Impact factor: 5.994

4.  Advanced cardiac amyloidosis associated with normal interventricular septal thickness: an uncommon presentation of infiltrative cardiomyopathy.

Authors:  Rahul Suresh; Martha Grogan; Joseph J Maleszewski; Patricia A Pellikka; Mazen Hanna; Angela Dispenzieri; Naveen L Pereira
Journal:  J Am Soc Echocardiogr       Date:  2014-01-18       Impact factor: 5.251

Review 5.  Nuclear imaging for cardiac amyloidosis.

Authors:  Walter Noordzij; Andor W J M Glaudemans; Simone Longhi; Riemer H J A Slart; Massimiliano Lorenzini; Bouke P C Hazenberg; Claudio Rapezzi
Journal:  Heart Fail Rev       Date:  2015-03       Impact factor: 4.214

Review 6.  Vascular comorbidities in familial Mediterranean fever.

Authors:  Z Birsin Ozçakar; Fatoş Yalçınkaya
Journal:  Rheumatol Int       Date:  2011-03-25       Impact factor: 2.631

7.  Nephrotic syndrome: A twist in the tail.

Authors:  Vinay Sakhuja; Vivekanand Jha; Amanjit Bal
Journal:  Indian J Nephrol       Date:  2008-10

8.  Prevalence and prognostic value of conduction disturbances at the time of diagnosis of cardiac AL amyloidosis.

Authors:  Michele Boldrini; Francesco Salinaro; Roberta Mussinelli; Ambra Raimondi; Alessio Alogna; Francesco Musca; Giovanni Palladini; Giampaolo Merlini; Stefano Perlini
Journal:  Ann Noninvasive Electrocardiol       Date:  2013-01-20       Impact factor: 1.468

Review 9.  Current and future circulating biomarkers for cardiac amyloidosis.

Authors:  Marco Luciani; Luca Troncone; Federica Del Monte
Journal:  Acta Pharmacol Sin       Date:  2018-05-17       Impact factor: 6.150

Review 10.  Transthyretin (TTR) cardiac amyloidosis.

Authors:  Frederick L Ruberg; John L Berk
Journal:  Circulation       Date:  2012-09-04       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.